Addnox (BPSPM1)
510(k) K243289
Addnox (BPSPM1) is a medical device (FDA Class II; FDA product code QGL, Transcutaneous Nerve Stimulator For Adhd) made by Nu Eyne Co., Ltd., cleared under FDA 510(k) K243289 on 16 Jan 2025, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK243289 | Date16 Jan 2025 | StatusActive |
Official records
- FDA 510(k) database K243289
From the FDA record
- Received by the FDA
- 18 Oct 2024
- FDA decision
- 16 Jan 2025 (Substantially Equivalent)
- FDA review time
- 90 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QGL
- Device class
- Class II
- Regulation
- 21 CFR Part 882.5898
- Advisory committee
- Neurology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QGL (Transcutaneous Nerve Stimulator For Adhd).